In a significant move towards digital transformation within the banking sector, Central Bank, a prominent Midwest regional bank, has announced a strategic partnership with Tata Consultancy Services (TCS) to modernize its core technology infrastructure. This collaboration aims to drive innovation, streamline customer onboarding processes, and support Central Bank’s continued growth. By integrating TCS BaNCS, Central […]
In a major development within the pharmaceutical industry, Aurobindo Pharma Limited (Aurobindo) announced it has received final approval from the US Food & Drug Administration (USFDA) for the manufacture and market of Mometasone Furoate Monohydrate Nasal Spray, 50 mcg/spray. This approval positions Aurobindo to launch the product in the first quarter of the fiscal year […]
In a significant development for the pharmaceutical industry, Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited, has secured final approval from the United States Food and Drug Administration (USFDA) to market its combination drug, Finasteride and Tadalafil Capsules USP, 5 mg/5 mg. This approval, announced recently, positions Zydus as the inaugural approved applicant for […]
In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has received final approval from the United States Food and Drug Administration (USFDA) for the manufacture and market of Chlorpromazine Hydrochloride Injection USP. The approval encompasses two formulations: 25 mg/mL and 50 mg/2 mL (25 mg/mL) in Single-Dose […]
In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received the United States Food & Drug Administration (USFDA) approval for Gabapentin Tablets USP, 600 mg and 800 mg. This approval marks a significant milestone for Strides, […]
In a significant development for the pharmaceutical industry, Aurobindo Pharma Limited has announced receiving the final nod from the United States Food and Drug Administration (USFDA) to manufacture and market Fingolimod Capsules, 0.5 mg. This approval marks a crucial milestone, as these capsules are recognized as bioequivalent and therapeutically equivalent to the reference listed drug, […]